Skip to main content
. Author manuscript; available in PMC: 2013 Jul 2.
Published in final edited form as: Nanomedicine (Lond). 2011 Apr 20;6(4):605–615. doi: 10.2217/nnm.11.21

Figure 4. Effect of antibody presentation density in the presence of urokinase at nominal number of anti-fibrin antibodies at zero, 10, 20 and 40 per particle.

Figure 4

Antibodies were simultaneously coupled to the particle along with 100 urokinase molecules presenting 0:10, 100:10, 100:20 or 100:40 urokinase:antibody per particle. *p < 0.05.